Related references
Note: Only part of the references are listed.Tuberculosis Vaccine Development: Progress in Clinical Evaluation
Suraj B. Sable et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Prevention of tuberculosis in macaques after intravenous BCG immunization
Patricia A. Darrah et al.
NATURE (2020)
Combo of two HIV vaccines fails its big test
Jon Cohen
SCIENCE (2020)
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
Jessica Marcandalli et al.
CELL (2019)
Augmenting the synergies of chemotherapy and immunotherapy through drug delivery
Jihoon Kim et al.
ACTA BIOMATERIALIA (2019)
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
Talar Tokatlian et al.
SCIENCE (2019)
Engineering Immune Tolerance with Biomaterials
Joshua M. Gammon et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
Kevin O. Saunders et al.
SCIENCE (2019)
Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases
Bijay Singh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses
Youhui Si et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses
Nuria Climent et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
E. Nemes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major
Shanshan Hu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
O. Van der Meeren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design
Joel Finney et al.
RETROVIROLOGY (2018)
Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
Charles B. Chesson et al.
SCIENTIFIC REPORTS (2018)
B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen
Sheng Hong et al.
IMMUNITY (2018)
Interrogation of Antigen Display on Individual Vaccine Nanoparticles for Achieving Neutralizing Antibody Responses against Hepatitis C Virus
Joseph D. Bazzill et al.
NANO LETTERS (2018)
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
Wei-Chiao Huang et al.
NATURE NANOTECHNOLOGY (2018)
Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
Talar Tokatlian et al.
SCIENTIFIC REPORTS (2018)
Nanoparticle Vaccines Against Infectious Diseases
Rashmirekha Pati et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice
Florian Brod et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria
Leslie S. Itsara et al.
FRONTIERS IN IMMUNOLOGY (2018)
Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size
Nathan Andrew Rohner et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Modular Peptide Amphiphile Micelles Improving an Antibody-Mediated Immune Response to Group A Streptococcus
John C. Barrett et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size
Nathan Andrew Rohner et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Modular Peptide Amphiphile Micelles Improving an Antibody-Mediated Immune Response to Group A Streptococcus
John C. Barrett et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach
Paola Martinez-Murillo et al.
IMMUNITY (2017)
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
Matthias Pauthner et al.
IMMUNITY (2017)
Host controls of HIV broadly neutralizing antibody development
Garnett Kelsoe et al.
IMMUNOLOGICAL REVIEWS (2017)
Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
Persephone Borrow et al.
IMMUNOLOGICAL REVIEWS (2017)
Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study
Hajar Rostami et al.
IMMUNOLOGY LETTERS (2017)
Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery
Brittany A. Bailey et al.
MOLECULAR PHARMACEUTICS (2017)
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144
Lautaro G. Perez et al.
PLOS ONE (2017)
Systems analysis of protective immune responses to RTS, S malaria vaccination in humans
Dmitri Kazmin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
Todd Bradley et al.
NATURE COMMUNICATIONS (2017)
A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers
Yaoying Wu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
What Have We Learnt about BCG Vaccination in the Last 20 Years?
Hazel M. Dockrell et al.
FRONTIERS IN IMMUNOLOGY (2017)
A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers
Yaoying Wu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
Nathanael P. McCurley et al.
PLOS ONE (2017)
Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers
Carolina Mora-Solano et al.
BIOMATERIALS (2017)
Engineering self -assembled materials to study and direct immune function
Lisa H. Tostanoski et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Biomaterial strategies for generating therapeutic immune responses
Sean H. Kelly et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Switching the Immunogenicity of Peptide Assemblies Using Surface Properties
Yi Wen et al.
ACS NANO (2016)
Thermal stability of self-assembled peptide vaccine materials
Tao Sun et al.
ACTA BIOMATERIALIA (2016)
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
Qi Yang et al.
ANALYTICAL CHEMISTRY (2016)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Immunopathogenesis of tuberculosis and novel mechanisms of vaccine activity
Lewis K. Schrager et al.
TUBERCULOSIS (2016)
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults
Alice Minhinnick et al.
VACCINE (2016)
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions
Christian Lienhardt et al.
PLOS MEDICINE (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Valentina Cappello et al.
SCIENTIFIC REPORTS (2016)
Multivalent Antigens for Promoting B and T Cell Activation
Nitasha R. Bennett et al.
ACS CHEMICAL BIOLOGY (2015)
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Masaru Kanekiyo et al.
CELL (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy
Jardin Leleux et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Ferritin family proteins and their use in bionanotechnology
Didi He et al.
NEW BIOTECHNOLOGY (2015)
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
Kwinten Sliepen et al.
RETROVIROLOGY (2015)
Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
Wilton B. Williams et al.
SCIENCE (2015)
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Dan H. Barouch et al.
SCIENCE (2015)
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles
Rajesh Kumar et al.
VACCINE (2015)
Designing malaria vaccines to circumvent antigen variability
Amed Ouattara et al.
VACCINE (2015)
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
Sampa Santra et al.
PLOS PATHOGENS (2015)
Vaccines Against Malaria
Amed Ouattara et al.
CLINICAL INFECTIOUS DISEASES (2015)
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
Peter Hraber et al.
AIDS (2014)
Design of Lipid Nanocapsule Delivery Vehicles for Multivalent Display of Recombinant Env Trimers in HIV Vaccination
Sharmila Pejawar-Gaddy et al.
BIOCONJUGATE CHEMISTRY (2014)
Gradated assembly of multiple proteins into supramolecular nanomaterials
Gregory A. Hudalla et al.
NATURE MATERIALS (2014)
Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses
Charles B. Chesson et al.
VACCINE (2014)
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
Petr O. Ilyinskii et al.
VACCINE (2014)
Titrating T-Cell Epitopes within Self-Assembled Vaccines Optimizes CD4+Helper T Cell and Antibody Outputs
Rebecca R. Pompano et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Selidji Todagbe Agnandji et al.
PLOS MEDICINE (2014)
Why HIV Virions Have Low Numbers of Envelope Spikes: Implications for Vaccine Development
John Schiller et al.
PLOS PATHOGENS (2014)
Morphologically Virus-Like Fullerenol Nanoparticles Act as the Dual-Functional Nanoadjuvant for HIV-1 Vaccine
Ligeng Xu et al.
ADVANCED MATERIALS (2013)
The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation
Jianjun Chen et al.
BIOMATERIALS (2013)
Nanoparticle diffusion in respiratory mucus from humans without lung disease
Benjamin S. Schuster et al.
BIOMATERIALS (2013)
HIV-1 neutralizing antibodies: understanding nature's pathways
John R. Mascola et al.
IMMUNOLOGICAL REVIEWS (2013)
Immunization of Macaques With Soluble HIV Type 1 and Influenza Virus Envelope Glycoproteins Results in a Similarly Rapid Contraction of Peripheral B-Cell Responses After Boosting
Christopher Sundling et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Construction and Characterization of Virus-Like Particles: A Review
Andris Zeltins
MOLECULAR BIOTECHNOLOGY (2013)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
Polymer multilayer tattooing for enhanced DNA vaccination
Peter C. DeMuth et al.
NATURE MATERIALS (2013)
Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection
Ganzhu Feng et al.
PLOS ONE (2013)
Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice
Iraklis C. Kourtis et al.
PLOS ONE (2013)
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Huub Schellekens et al.
PHARMACEUTICAL RESEARCH (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Jean-Philippe Julien et al.
SCIENCE (2013)
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Joseph Jardine et al.
SCIENCE (2013)
A Self-Adjuvanting Supramolecular Vaccine Carrying a Folded Protein Antigen
Gregory A. Hudalla et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1
Sheetij Dutta et al.
PLOS PATHOGENS (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Vaccine delivery using nanoparticles
Anthony E. Gregory et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Modulating Adaptive Immune Responses to Peptide Self-Assemblies
Jai S. Rudra et al.
ACS NANO (2012)
Self-Assembled Peptide Amphiphile Micelles Containing a Cytotoxic T-Cell Epitope Promote a Protective Immune Response In Vivo
Matthew Black et al.
ADVANCED MATERIALS (2012)
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Stacey L. Demento et al.
BIOMATERIALS (2012)
Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope
Jai S. Rudra et al.
BIOMATERIALS (2012)
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Eleonore Froehlich
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution
Yan Zhuang et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
David C. Montefiori et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection
Fangliu Yu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates
Alexandra J. Spencer et al.
PLOS ONE (2012)
Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
Stephen A. Kaba et al.
PLOS ONE (2012)
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
James J. Moon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Engineering Approaches to Immunotherapy
Melody A. Swartz et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Targeting the lymphatics using dendritic polymers (dendrimers)
Lisa M. Kaminskas et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Enzyme Digests Eliminate Nonfunctional Env from HIV-1 Particle Surfaces, Leaving Native Env Trimers Intact and Viral Infectivity Unaffected
Ema T. Crooks et al.
JOURNAL OF VIROLOGY (2011)
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi et al.
NATURE (2011)
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
James J. Moon et al.
NATURE MATERIALS (2011)
In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
Christopher M. Jewell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
Dmitri Smirnov et al.
VACCINE (2011)
Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration
Mahamoud Sama Cherif et al.
VACCINE (2011)
Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
Mariusz Skwarczynski et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems
Deepa Mohanan et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
Samuel K. Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A self-assembling peptide acting as an immune adjuvant
Jai S. Rudra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
Sachiko Hirosue et al.
VACCINE (2010)
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Samuel K. Lai et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Micro- and macrorheology of mucus
Samuel K. Lai et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules
Siow-Feng Chong et al.
BIOMATERIALS (2009)
A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria
Stephen A. Kaba et al.
JOURNAL OF IMMUNOLOGY (2009)
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces
Bette T. Korber et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Nanotechnology in vaccine delivery
Laura J. Peek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
The oligomerization domain of C4-binding protein (C4bp) acts as an adjuvant, and the fusion protein comprised of the 19-kilodalton merozoite surface protein 1 fused with the murine C4bp domain protects mice against malaria
Solabomi A. Ogun et al.
INFECTION AND IMMUNITY (2008)
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria
Nathan W. Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
Tri Giang Phan et al.
NATURE IMMUNOLOGY (2007)
The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles
Kathryn A. Pape et al.
IMMUNITY (2007)
Activating B cell signaling with defined multivalent ligands
Erik B. Puffer et al.
ACS CHEMICAL BIOLOGY (2007)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Role of target geometry in phagocytosis
JA Champion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
PL Moore et al.
JOURNAL OF VIROLOGY (2006)
Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation
YM Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pathogen recognition and development of particulate vaccines: Does size matter?
Sue D. Xiang et al.
METHODS (2006)
The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node
M Sixt et al.
IMMUNITY (2005)
Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis
M Bivas-Benita et al.
VACCINE (2004)
Determinants of autoantibody induction by conjugated papillomavirus virus-like particles
B Chackerian et al.
JOURNAL OF IMMUNOLOGY (2002)
C-type lectin receptors on dendritic cells and Langerhans cells
CG Figdor et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Chitosan-based nanoparticles for topical genetic immunization
ZR Cui et al.
JOURNAL OF CONTROLLED RELEASE (2001)
B cells extract and present immobilized antigen: implications for affinity discrimination
FD Batista et al.
EMBO JOURNAL (2000)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Share Paper
